Keyphrases
Medical Management
100%
Surgical Management
100%
Superficial Basal Cell Carcinoma
100%
Mohs Micrographic Surgery
36%
5-fluorouracil (5-FU)
18%
Imiquimod
18%
Therapeutic Strategies
9%
High Incidence
9%
Recurrence Rate
9%
Surgical Treatment
9%
Excision
9%
Adjunctive Therapy
9%
Patient Outcomes
9%
Treatment Modalities
9%
Histological Subtypes
9%
Treatment Choice
9%
Economic Cost
9%
Tumor Clearance
9%
Non-surgical Treatment
9%
Laser Therapy
9%
Topical Application
9%
Large Defects
9%
Management Protocol
9%
Systemic Retinoids
9%
Curettage
9%
Defect Size
9%
Comprehensive Literature Review
9%
Incomplete Excision
9%
Light Therapy
9%
Morbidity Costs
9%
Standardized Management
9%
Electrodesiccation
9%
Tumor Island
9%
Subclinical Extension
9%
Medicine and Dentistry
Superficial Basal Cell Carcinoma
100%
Mohs Surgery
36%
Neoplasm
18%
Fluorouracil
18%
Imiquimod
18%
Health Care Cost
9%
Recurrent Disease
9%
Adjuvant Therapy
9%
Recurrence Risk
9%
Conservative Treatment
9%
Topical Drug Administration
9%
Retinoid
9%
Low Level Laser Therapy
9%
Phototherapy
9%
Electrodesiccation and Curettage
9%
Immunology and Microbiology
Basal Cell
100%
Imiquimod
18%